Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01)

The summary for the Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01): This Funding Opportunity Announcement encourages applications using community-engaged research methods to investigate the potential health risks of environmental exposures of concern to the community and to implement an environmental public health action plan based on research findings. The overall goal is to support changes to prevent or reduce exposure to harmful environmental exposures and improve the health of a community.

Federal Grant Title:	Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Environment Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-16-083
Type of Funding:	Grant
CFDA Numbers:	93.113, 93.361
CFDA Descriptions:	Environmental Health; Nursing Research
Current Application Deadline:	May 7, 2019
Original Application Deadline:	May 7, 2019
Posted Date:	Jan 13, 2016
Creation Date:	Jan 13, 2016
Archive Date:	Jun 7, 2019
Total Program Funding:
Maximum Federal Grant Award:	none
Minimum Federal Grant Award:	none
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: City or township governments
Public and State controlled institutions of higher education
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Additional Information on Eligibility: See full announcement for complete details.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PA-16-083.html
Grant Announcement Contact: eRA Service Desk Monday to Friday 7 am to 8 pm ET http://grants.nih.gov/support/ Phone 1-866-504-9552
Grants Info

National Institutes of Health 301-496-3405
Similar Government Grants: • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clini...; • Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic ...; • Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clini...; • Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed); • Outstanding New Environmental Scientist Award (ONES); • Environmental Health Sciences Core Center Grants; • Leiomyomata Uteri: Basic Science and Translational Research
More Grants from the National Institutes of Health: • The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...; • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional); • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...